Sacubitril/Valsartan contributes to improving the diabetic kidney disease and regulating the gut microbiota in mice

BACKGROUND: Diabetic kidney disease (DKD), as a serious microvascular complication of diabetes, has limted treatment options. It is reported that the Sacubitril/Valsartan (Sac/Val) can improve kidney function, and the disordered gut microbiota and part of its metabolites are related to the developme...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Peipei, Guo, Ruixue, Bai, Xiwen, Cui, Wen, Zhang, Yiding, Li, Huangmin, Shang, Jin, Zhao, Zhanzheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802116/
https://www.ncbi.nlm.nih.gov/pubmed/36589853
http://dx.doi.org/10.3389/fendo.2022.1034818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802116/
https://www.ncbi.nlm.nih.gov/pubmed/36589853
http://dx.doi.org/10.3389/fendo.2022.1034818

Ejemplares similares